There are 2789 resources available
119O - Event-free survival (EFS), overall survival (OS), and safety of adding veliparib (V) plus carboplatin (Cb) or carboplatin alone to neoadjuvant chemotherapy in triple-negative breast cancer (TNBC) after ≥4 years of follow-up: BrighTNess, a randomized phase III trial
Presenter: Sibylle Loibl
Session: Proffered Paper session - Breast cancer, early stage
Resources:
Abstract
Slides
Webcast
Invited Discussant LBA27
Presenter: Srikala Sridhar
Session: Proffered Paper session - Genitourinary tumours, non-prostate 1
Resources:
Slides
Webcast
Q&A and live discussion
Presenter: Silke Gillessen
Session: Proffered Paper session - Genitourinary tumours, non-prostate 1
Resources:
Slides
Webcast
Invited Discussant 651O and 652O
Presenter: Enrique Grande
Session: Proffered Paper session - Genitourinary tumours, non-prostate 1
Resources:
Slides
Webcast
Q&A and live discussion
Presenter: Silke Gillessen
Session: Proffered Paper session - Genitourinary tumours, non-prostate 1
Resources:
Slides
Webcast
Invited Discussant 1170O and LBA65
Presenter: Pilar Garrido Lopez
Session: Proffered Paper session - Non-metastatic NSCLC and other thoracic malignancies
Resources:
Slides
Webcast
Q&A and live discussion
Presenter: Pilar Garrido Lopez
Session: Proffered Paper session - Non-metastatic NSCLC and other thoracic malignancies
Resources:
Slides
Webcast
Invited Discussant LBA66 and LBA42
Presenter: Oliver Gautschi
Session: Proffered Paper session - Non-metastatic NSCLC and other thoracic malignancies
Resources:
Slides
Webcast
Q&A and live discussion
Presenter: Oliver Gautschi
Session: Proffered Paper session - Non-metastatic NSCLC and other thoracic malignancies
Resources:
Slides
Webcast
Invited Discussant LBA32 and 721O
Presenter: Rosalind Glasspool
Session: Proffered Paper session - Gynaecological cancers
Resources:
Slides
Webcast